Authors:
ZEDER K
WALLER EK
REDEI I
CONNAGHAN DG
FLEMING WH
GELLER RB
HEFFNER LT
HILLYER CD
HOLDEN J
HOLLAND K
JONES W
MCCOLLUM J
MOGUL M
PHILLIPS C
RODEY G
WINGARD JR
WINTON E
YEAGER AM
DEVINE S
Citation: K. Zeder et al., IMPACT OF DONOR LYMPHOCYTE INFUSION FOR HEMATOLOGICAL MALIGNANCY RELAPSED AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Cancer research, therapy & control, 5(4), 1998, pp. 221-228
Authors:
HOLLAND HK
BRAY RA
OTOOLE K
HOLDEN JT
CONNAGHAN DG
HEFFNER LT
WALLER EK
WINTON EF
YEAGER AM
Citation: Hk. Holland et al., PRESENCE OF MINIMAL RESIDUAL DISEASE (MRD) IN ACUTE MYELOGENOUS LEUKEMIA (AML) PATIENTS PREALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IS ASSOCIATED WITH A LOWER RELAPSE-FREE SURVIVAL (RFS), Experimental hematology, 25(8), 1997, pp. 621-621
Authors:
GELLER RB
DEVINE SM
OTOOLE K
PERSONS L
KELLER J
MAUER D
HOLLAND HK
DIX SP
PIOTTI M
REDEI I
CONNAGHAN G
HEFFNER LT
HILLYER CD
WALLER EK
WINTON EF
WINGARD JR
Citation: Rb. Geller et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH MATCHED UNRELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES USING A PREPARATIVE REGIMENOF HIGH-DOSE CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION, Bone marrow transplantation, 20(3), 1997, pp. 219-225
Authors:
TIRONA MRBT
GORDON DS
CROCKER I
ELEY JW
YORK R
HEFFNER LT
WINTON EF
VOGLER WR
Citation: Mrbt. Tirona et al., HIGH-DOSE CYCLOPHOSPHAMIDE, FRACTIONATED TOTAL-BODY IRRADIATION WITH INVOLVED FIELD IRRADIATION AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MALIGNANT-LYMPHOMA, Leukemia & lymphoma, 20(3-4), 1996, pp. 249-257
Authors:
HOLLAND HK
DIX SP
GELLER RB
DEVINE SM
HEFFNER LT
CONNAGHAN DG
HILLYER CD
HUGHES LL
MILLER RL
MOORE MR
WINTON EF
WINGARD JR
Citation: Hk. Holland et al., MINIMAL TOXICITY AND MORTALITY IN HIGH-RISK BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN PLUS AUTOLOGOUS MARROW STEM-CELL TRANSPLANTATION AND COMPREHENSIVE SUPPORTIVE CARE, Journal of clinical oncology, 14(4), 1996, pp. 1156-1164
Authors:
VOGLER WR
BERDEL WE
WINTON EF
GORDON DS
GELLER RB
HEFFNER LT
BROCHSTEIN JA
BEVERIDGE RA
DALTON WS
MILLER KB
LAZARUS HM
Citation: Wr. Vogler et al., LONG-TERM FOLLOW-UP OF EDELFOSINE PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA, Experimental hematology, 24(9), 1996, pp. 615-615
Authors:
DIX SP
WINGARD JR
MULLINS RE
JERKUNICA I
DAVIDSON TG
GILMORE CE
YORK RC
LIN LS
DEVINE SM
GELLER RB
HEFFNER LT
HILLYER CD
HOLLAND HK
WINTON EF
SARAL R
Citation: Sp. Dix et al., ASSOCIATION OF BUSULFAN AREA-UNDER-THE-CURVE WITH VENOOCCLUSIVE DISEASE FOLLOWING BMT, Bone marrow transplantation, 17(2), 1996, pp. 225-230
Authors:
MIYAHARA TT
DIX SP
DEVINE SM
HOLLAND HK
CONNAGHAN DG
FLEMING WH
GELLER RB
HEFFNER LT
HILLYER CD
WALLER EK
WINTON EF
WINGARD JR
Citation: Tt. Miyahara et al., EVALUATION OF SUPPORTIVE CARE GUIDELINES FOR MONITORING BREAST-CANCERBONE-MARROW TRANSPLANT (BMT) PATIENTS IN THE OUTPATIENT SETTING, Blood, 86(10), 1995, pp. 838-838
Authors:
HOLLAND HK
BRAY AM
GELLER RB
DEVINE SM
MCCOLLUM J
CONNAGHAN DG
FLEMING WH
HEFFNER LT
HILLYER C
WALLER EK
WINTON EF
WINGARD JR
Citation: Hk. Holland et al., TRANSPLANTATION OF HLA-IDENTICAL POSITIVELY SELECTED CD34-BLOOD (PBSC) AND MARROW (BM) FROM RELATED DONORS RESULTS IN PROMPT ENGRAFTMENT AND LOW INCIDENCE OF GVHD IN RECIPIENTS UNDERGOING ALLOGENEIC TRANSPLANTATION( CELLS OF PERIPHERAL), Blood, 86(10), 1995, pp. 1543-1543
Authors:
REDEI S
GELLER RB
DEVINE S
OTOOLE K
PERSONS L
HOLLAND HK
CONNAGHAN G
FLEMING WH
HEFFNER LT
HILLYER C
WALLER EK
WINTON EF
WINGARD JR
Citation: S. Redei et al., RISK-FACTORS FOR SEVERE ACUTE-RENAL-FAILURE (ARF) AFTER MATCHED UNRELATED DONOR TRANSPLANTATION (MUDT), Blood, 86(10), 1995, pp. 1552-1552
Authors:
DEVINE SM
GELLER RB
DIX SP
CONNAGHAN DG
FLEMING WH
HEFFNER LT
HILLYER CD
HOLLAND HK
WALLER EK
WINTON EF
WINGARD JR
Citation: Sm. Devine et al., TACROLIMUS (FK506) COMBINED WITH METHOTREXATE (MTX) IS EFFECTIVE IN PREVENTING ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) FOLLOWING RELATED DONOR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 1569-1569
Authors:
SHUSTER MW
WEI LX
SCHULMAN P
KOLITZ J
BUCHBINDER A
ALLEN S
LICHTMAN SM
GELLER RB
DEVINE SM
HEFFNER LT
MANN K
Citation: Mw. Shuster et al., CRL-1336 - FIRST OF A NOVEL CLASS OF DRUGS USED TO REVERSE MULTIDRUG-RESISTANCE (MDR1) GENE-EXPRESSION IN LEUKEMIA, Blood, 86(10), 1995, pp. 2069-2069
Authors:
DEVINE SM
WINTON EF
HOLLAND HK
GELLER RB
HEFFNER LT
HILLYER CD
MORRIS LE
RODEY GE
BEVERIDGE R
LYNCH J
KLEIN L
DIX SP
WINGARD JR
Citation: Sm. Devine et al., SIMULTANEOUS ADMINISTRATION OF INTERLEUKEN-6 (RHIL-6) AND NEUPOGEN(R)(RHG-CSF) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FORBREAST-CANCER (BCA), Blood, 84(10), 1994, pp. 10000089-10000089
Authors:
GELLER RB
MORRIS L
WINTON EF
BRAY R
HEFFNER LT
HOLLAND KH
GILMORE C
DEVINE S
FARHI D
JAMISON K
WINGARD JR
Citation: Rb. Geller et al., INTENSIVE TIME-SEQUENTIAL INDUCTION THERAPY WITH VP-16, MITOXANTRONE AND ARA-C FOR PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA (AML) OR REFRACTORY RELAPSE ACUTE-LEUKEMIA - A POTENTIAL ROLE FOR GM-CSF TO ENHANCE RECRUITMENT, Blood, 84(10), 1994, pp. 10000144-10000144
Authors:
HOLLAND HK
HEFFNER LT
GELLER RB
DEVINE SM
HILLYER CD
WINTON EF
SARAL R
WINGARD JR
Citation: Hk. Holland et al., BONE-MARROW TRANSPLANTATION (BMT) FOR INDOLENT LYMPHOMA UTILIZING BUSULFAN (BU), CYCLOPHOSPHAMIDE (CY) AND ETOPOSIDE (E) FOLLOWED BY MAINTENANCE ALPHA-INTERFERON (IF) - 2-YEAR FOLLOW-UP RESULTS, Blood, 84(10), 1994, pp. 10000209-10000209
Authors:
DEVINE SM
GELLER RB
HOLLAND HK
MORRIS LE
WINTON EF
HEFFNER LT
HILLYER CD
RODEY GE
DIX SP
OTOOLE K
ROUTENBERG K
VOGLER WR
MAUER D
ARO R
FITZSIMMONS WE
WINGARD JR
Citation: Sm. Devine et al., FK506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST-DISEASE (GVHD) AFTER MATCHED UNRELATED DONOR (MUD) MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000341-10000341
Authors:
DIX SP
MULLINS RE
JERKUNICA I
DAVIDSON TG
GILMORE CE
YORK RC
LIN LS
DEVINE SM
GELLER RB
HEFFNER LT
HILLYER CD
HOLLAND HK
SEAY TE
VOGLER WR
WINTON EF
WINGARD JR
SARAL R
Citation: Sp. Dix et al., ASSOCIATION OF BUSULFAN AREA-UNDER-THE-CURVE (AUC) WITH VENOOCCLUSIVEDISEASE (VOD) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT), Blood, 82(10), 1993, pp. 10000418-10000418
Authors:
GELLER RB
SIDHU GK
BRAY K
GILMORE C
KLEIN L
ROTHFIELD C
HEFFNER LT
HOLLAND HK
SEAY TE
WINTON EF
WINGARD JR
SARAL R
Citation: Rb. Geller et al., INTENSIVE TIMED SEQUENTIAL INDUCTION THERAPY WITH VP-16, MITOXANTRONEAND ARA-C FOR ADULT PATIENTS WITH ACUTE-LEUKEMIA, Blood, 82(10), 1993, pp. 10000538-10000538